Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Niacin and Hexamethonium

supplement:

Niacin

Research Papers that Mention the Interaction

Twenty‐three (out of twenty‐five neurones tested) received nicotinic fast excitatory synaptic inputs (fast e.p.s.p.s) that were blocked reversibly by hexamethonium and mimicked by acetylcholine.
The Journal of physiology  •  1987  |  View Paper
Hexamethonium , a blocker of nicotinic ganglionic transmission, was able to prevent the AITC-evoked inhibitory effect, an effect that was also observed with the opioid antagonist naloxone.
Pharmacology  •  2016  |  View Paper
Hexamethonium , a blocker of nicotinic ganglionic transmission, at 300 μmol/l and 1 mmol/l augmented the twitch contractions by 21% and 35%, respectively.
Neuroscience Letters  •  2014  |  View Paper
When nicotinic and muscarinic receptors were blocked by hexamethonium and atropine, 20 Hz stimulation for 10 s initiated a sEPSP in all innervated neurones.
The Journal of physiology  •  2007  |  View Paper
These effects were blocked by the application of the nicotinic antagonist hexamethonium.
American journal of physiology. Renal physiology  •  2006  |  View Paper
The nicotinic antagonist Hexamethonium reduced the evoked flow by approximately 50% (30 mg/kg), while the muscarinic antagonist Atropin did not influence the stimulation evoked blood flow.
Neuroscience Letters  •  2005  |  View Paper
Nicotinic blockade by adding hexamethonium into the perfused solution inhibited long-term potentiation induction.
European journal of pharmacology  •  1999  |  View Paper
3 The occlusive effects of nicotinic agonists on ATP‐gated currents were blocked by the nicotinic receptor/ion channel blocker hexamethonium (150 μM).
The Journal of physiology  •  1998  |  View Paper
Nicotinic and muscarinic M1 receptors were blocked with hexamethonium and pirenzepine, respectively.
Canadian journal of anaesthesia = Journal canadien d'anesthesie  •  1997  |  View Paper
In contrast, when the nicotinic positive feedback was prevented by hexamethonium , atropine failed to enhance the release.
The Journal of pharmacology and experimental therapeutics  •  1997  |  View Paper
Show More